Literature DB >> 4988026

Australia antigen and autoantibodies in chronic hepatitis.

T L Vischer.   

Abstract

The sera of 110 patients with chronic hepatitis and adequate controls were examined for antibodies to smooth muscle (S.M.), mitochondria (M.), and for antinuclear factors by the immunofluorescence method, and for Australia (Au(1)) antigen by a modified micro-Ouchterlony immunodiffusion technique. Twelve out of 13 patients with primary biliary cirrhosis had M. antibodies, two had antinuclear factor, and none had Au(1) in their sera. In chronic aggressive hepatitis 23.5% of the sera contained antinuclear factor, 13% S.M. antibodies, 10.5% M. antibodies, and 22% Au(1) antigen. Of the 12 patients with chronic persistent hepatitis, one had antinuclear factor, one S.M. antibodies, and three Au(1) antigen.The most striking finding was a mutual exclusion between Au(1) antigen and M. and S.M. antibodies. None of the 33 patients with one or the other form of chronic hepatitis and M. or S.M. antibodies had Au(1) antigen; 22 out of 77 (28%) patients without such antibodies were positive.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4988026      PMCID: PMC1700632          DOI: 10.1136/bmj.2.5711.695

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  20 in total

1.  SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS.

Authors:  J G WALKER; D DONIACH; I M ROITT; S SHERLOCK
Journal:  Lancet       Date:  1965-04-17       Impact factor: 79.321

2.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

3.  [Immunofluorescent investigations on liver biopsy specimens with FITC-labeled protein from organs].

Authors:  F K Kössling; R Dietz
Journal:  Verh Dtsch Ges Pathol       Date:  1969

4.  Chronic hepatic injury following experimental viral hepatitis in the dog.

Authors:  R Preisig; D Gocke; T Morris; S E Bradley
Journal:  Experientia       Date:  1966-10-15

Review 5.  A unified concept of autoimmune hepatitis.

Authors:  D Doniach; J G Walker
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

6.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

7.  [On the induction of an active chronic hepatitis by heterologic soluble liver proteins].

Authors:  F K Kössling
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1968

8.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

9.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

10.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

View more
  14 in total

1.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.

Authors:  F J Dudley; M J O'Shea; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

Review 3.  [Hepatitis-associated antigen: clinical and immunological significance].

Authors:  P A Berg
Journal:  Klin Wochenschr       Date:  1972-02-01

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

5.  Viral hepatitis related antigens in 'autoimmune' hepatic disorders.

Authors:  D Doniach; S Del Prete; D S Dane; J H Walsh
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

6.  Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

Authors:  F J Dudley; M J O'Shea; A Ajdukiewicz; S Sherlock
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

7.  Australia antigen and primary biliary cirrhosis.

Authors:  R N MacSween; A A Laiwah; A A Busuttil; M A Thomas; S K Ross; G Watkinson; I Millman; B S Blumberg
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

8.  Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction.

Authors:  M Torisu; T Yokoyama; A L Durst; G Schroter; C W Putnam; C G Halgrimson; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

9.  Chronic active hepatitis in patients with and without hepatitis B surface antigenemia.

Authors:  A Pár; K Barna; G Bajtai; M Balázs; A Patakfalvi; A Gógl
Journal:  Infection       Date:  1977       Impact factor: 3.553

10.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases.

Authors:  U Tage-Jensen; W Arnold; O Dietrichson; F Hardt; U Hopf; K H Meyer Zum Büschenfelde; J O Nielsen
Journal:  Br Med J       Date:  1977-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.